Anticipating that the tumor environment in CLL patients may affect SIGLEC10 expression, we also included normal naïve CD5− B cells, naïve CD5+ B cells, and CD27+ memory B cells from 5 age‐matched healthy donors. The gene discussed is CD5; the disease is neoplasm.